Clinical Investigation

Occlutech is conducting clinical investigations or studies to investigate the safety and efficacy of different occluders it is developing or marketing.

Products in human trials include occluders intended for percutaneous closure of Atrial Septal Defect (ASD), Left Atrial Appendages (LAA), as well as a number of other, undisclosed indications.

The Company intends to use results from these and planned future studies to support both European and international product registration, as well as to support sales and marketing of its devices.